GlassScriptPhysician profile
Carmen Colon
NPI 1215433933
$2,267.84
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $207 · 2022: $1,013 · 2023: $1,048.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,048.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $667.69 | 2021-2023 | Stiolto Respimat, Spiriva Respimat |
| Harmony Biosciences LLC | $407.01 | 2022-2023 | Wakix |
| Astrazeneca Pharmaceuticals LP | $294.97 | 2021-2023 | Breztri |
| Jazz Pharmaceuticals INC. | $144.00 | 2021-2023 | |
| Mylan Specialty L.P. | $133.02 | 2021-2023 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $97.33 | 2022-2023 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $91.30 | 2021-2023 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $62.58 | 2021-2023 | Recarbrio, Dificid, Zerbaxa |
| Mallinckrodt Hospital Products INC. | $59.66 | 2023 | Acthar |
| Alexion Pharmaceuticals, INC. | $43.21 | 2022 | |
| Inspire Medical Systems, INC. | $42.74 | 2023 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $42.68 | 2021-2022 | |
| Genzyme Corporation | $38.26 | 2022 | |
| Insmed, INC. | $27.04 | 2023 | Arikayce |
| Pfizer INC. | $26.42 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $24.98 | 2023 | Prolastin-C Liquid |
| Philips North America LLC | $23.76 | 2023 | |
| Resmed Corp | $18.68 | 2022 | |
| Ethicon US, LLC | $16.68 | 2021 | |
| Inogen, INC. | $5.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmen Colon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.